Description
NEXOME CAPITAL MARKETS LIMITED (BSE: 508905) has fixed a record date of 05 March 2026 for a rights issue offering 1 new equity share for every 2 shares held at Rs. 75/- per share (face value Rs. 10/- at a premium of Rs. 65/-).
Summary
BSE has notified trading members that NEXOME CAPITAL MARKETS LIMITED (Scrip Code: 508905) has fixed 05 March 2026 as the record date for its rights issue. Equity shares of the company will trade on an ex-rights basis effective 05 March 2026 under Rolling Settlement DR-833/2025-2026.
Key Points
- Company: NEXOME CAPITAL MARKETS LIMITED (BSE Code: 508905)
- Rights Ratio: 1 new equity share for every 2 existing equity shares held
- Issue Price: Rs. 75/- per share (face value Rs. 10/- + premium Rs. 65/-)
- Record Date: 05 March 2026
- Ex-Rights Date: 05 March 2026
- Settlement Number: DR-833/2025-2026
- Segment: Dematerialised Securities – Rolling Settlement Segment
Regulatory Changes
No regulatory changes introduced. This is a routine corporate action notification under BSE’s listing compliance framework.
Compliance Requirements
- Trading members must ensure all transactions in NEXOME CAPITAL MARKETS LIMITED equity shares are executed on an ex-rights basis with effect from 05 March 2026.
- Members should update their systems to reflect the ex-rights adjustment from the specified record date and settlement number.
Important Dates
| Event | Date |
|---|---|
| Circular Date | 27 February 2026 |
| Record Date | 05 March 2026 |
| Ex-Rights Effective Date | 05 March 2026 |
| Settlement Reference | DR-833/2025-2026 |
Impact Assessment
This circular has a medium impact on existing shareholders of NEXOME CAPITAL MARKETS LIMITED. Shareholders holding shares as of the record date (05 March 2026) will be entitled to subscribe to 1 new share for every 2 shares held at Rs. 75/- per share. The ex-rights adjustment may result in a dilution-adjusted price correction in the scrip from the record date. Broader market impact is minimal given the company-specific nature of the action.
Impact Justification
Standard rights issue corporate action affecting existing shareholders of NEXOME CAPITAL MARKETS LIMITED; trading members must transact on an ex-rights basis from the record date. Impact is limited to shareholders of a single small-cap company.